Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 4,309-4,320 of 10,612

Behavioral study icon

CompletedNCT01411774

D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric OCD (OCD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDBehavioralFrom 7 Years to 17 Years

Countries: United States
Sponsor: University of South Florida
Condition: OCD

Behavioral study icon

CompletedNCT01981759

D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 18 Years to 68 Years

Countries: United States
Sponsor: NYU Langone Health
Condition: Schizophrenia

Behavioral study icon

CompletedNCT00963924

D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Schizophrenia

Behavioral study icon

CompletedNCT00864123

D-Cycloserine Augmentation of Therapy for Pediatric OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDBehavioralFrom 8 Years to 17 Years

Countries: United States
Sponsor: University of South Florida
Condition: OCD

Behavioral study icon

CompletedNCT01172873

D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDBehavioralFrom 12 Years to 17 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: OCD

Drug study icon

CompletedNCT00759473

D-Cycloserine Facilitation of Cocaine - Cue Extinction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Mental healthDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Mental health

Drug study icon

CompletedNCT02156908

D-serine and Cognitive Remediation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Nathan Kline Institute for Psychiatric Research
Condition: Schizophrenia

Drug study icon

SuspendedNCT05046353

D-serine AudRem: R33 Phase

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Schizophrenia

Drug study icon

CompletedNCT03711500

D-serine Augmentation of Neuroplasticity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Schizophrenia

Drug study icon

CompletedNCT00826202

D-serine for the Schizophrenia Prodrome

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 13 Years to 35 Years

Countries: United States
Sponsor: Nathan Kline Institute for Psychiatric Research
Condition: Schizophrenia

Behavioral study icon

CompletedNCT00237809

D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Behavioral study icon

CompletedNCT02493218

D-Stress Baltimore: School-based Mindfulness Instruction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 9 Years to 18 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: PTSD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.